xerostomia. Disturbances of salivary secretion
Conditions
Interventions
Intervention group: 980nm Diod laser was applied bilaterally on submandibular glands and parotid glands extra orally (6j , 300mW, for 20 seconds) and it was applied intraorally on sublingual glands (
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All male and female patients who are referred to Bandar Anzali health network and suffering from xerostomia based on the valid Fox questionnaire and their non-stimulated saliva flow rate is less than 0.1 ml per 5 minutes
Exclusion criteria
Exclusion criteria: Patients under radiation therapy People with Sjögren's syndrome People with cancer People who take xerogenic drug (antiretroviral, antihistamine, anticholinergic, narcotic anticancer, tricyclic antidepressant, anti-inflammatory, anti-congestion drugs) Patients under other treatments of xerostomia ( salivary stimulants, electrical stimulation, acupuncture, and the use of saliva substitutes).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salivary flow rate. Timepoint: 5 minutes before and after treatment every other day. Method of measurement: amount (volume and weigh ) of saliva. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Basirat
Guilan University of Medical Sciences
Outcome results
None listed